Depression Clinical Trials in Philadelphia

Showing 41-60 of 232 trials

Evaluation of the PACE/PACENET BHL Clinical Program

NCT02463266

The SUpporting Seniors Receiving Treatment And INtervention (SUSTAIN) program is a telephone-based clinical service designed to help identify and manage behavioral health issues among PACE/PACENET enrollees. The purpose of the current project is to a) explore moderators of treatment response among beneficiaries in the SUSTAIN Clinical Program and b) to evaluate the sustained clinical effects of the program.

DepressionAnxietyPain, Chronic

University of Pennsylvania4,000 participantsStarted Mar 2014

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

NCT02614547

This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the efficacy, safety, and pharmacokinetics of SAGE-547 Injection in adult female participants diagnosed with severe postpartum depression.

Severe Postpartum Depression

Supernus Pharmaceuticals, Inc.21 participantsStarted Dec 2015

Atlanta, Georgia, United States • Worcester, Massachusetts, United States • Chapel Hill, North Carolina, United States +1 more locations

COMPLETEDNA< 1 mile

Neurofeedback to Treat Depression

NCT05169346

This study tests the efficacy of a new psychotherapeutic strategy for reducing negative attention bias (and therefore depression severity) in participants with MDD (60 in R61 phase and 80 in R33 Phase). This real-time fMRI neurofeedback therapy uses cloud-based pattern classification to decode a patient's attentional state and dynamically modulate task stimuli (in a closed loop) based on this state.

MDD

University of Pennsylvania71 participantsStarted May 2022

Philadelphia, Pennsylvania, United States

Evaluation of the PACE/PACENET BHL Clinical Program

A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression

Neurofeedback to Treat Depression

Depression Trials in Other Cities

Engaging Suicidal Patients in Mental Health Treatment

Intensive TMS for Bipolar Depression

A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD

A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Depression Trial)

Positive Processes and Transition to Health (PATH)

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression

ALTO-100 in Bipolar Disorder With Depression (BD-D)

Virtual Neuro-Navigation System for Personalized Community Based TMS

Phase 2b Study of ALTO-100 in MDD

A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder

Pramipexole to Enhance Social Connections

XEN1101 for Major Depressive Disorder

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

Healthy Lifestyle Intervention for High-Risk Minority Pregnant Women

Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention

Digital Single Session Intervention for Youth Mental Health

Health Education Materials With/Out a Physical Activity Program for Patients Who Have Undergone Treatment for High-Risk Stage II or Stage III Colon Cancer

Other Conditions in Philadelphia